Literature DB >> 17479672

Could epithelial ovarian cancer be associated with chlamydial infection?

A Wong1, A B Maclean, S J Furrows, G L Ridgway, P J Hardiman, C W Perrett.   

Abstract

PURPOSE OF INVESTIGATION: Epithelial ovarian cancer (EOC) is the leading cause of death from gynaecological malignancy in the UK. The pathogenesis of this disease is poorly understood. Our hypothesis was that chlamydial infection might play a role in the pathogenesis of EOC.
METHODS: 122 serum samples of patients undergoing surgery for benign or malignant gynaecological conditions were analysed. There was a total of 41 patients with EOC (33.6%), 27 with benign cystadenomas (22.1%) and 54 with normal ovaries (44.3%).
RESULTS: There was a higher incidence of IgA seropositivity and lower incidence of IgG seropositivity in the EOC group compared with the other groups; however, this was not statistically significant. There was no statistical difference in the serum IgM antibodies to chlamydia in the three different groups.
CONCLUSION: Although chronic infection and persistent inflammation may contribute to the pathogenesis of EOC, and chlamydia is a common genital tract pathogen, our study did not find an association between chlamydia and EOC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17479672

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  6 in total

1.  Antibodies Against Chlamydia trachomatis and Ovarian Cancer Risk in Two Independent Populations.

Authors:  Britton Trabert; Tim Waterboer; Annika Idahl; Nicole Brenner; Louise A Brinton; Julia Butt; Sally B Coburn; Patricia Hartge; Katrin Hufnagel; Federica Inturrisi; Jolanta Lissowska; Alexander Mentzer; Beata Peplonska; Mark E Sherman; Gillian S Wills; Sarah C Woodhall; Michael Pawlita; Nicolas Wentzensen
Journal:  J Natl Cancer Inst       Date:  2019-02-01       Impact factor: 13.506

2.  Chlamydia trachomatis and Mycoplasma genitalium plasma antibodies in relation to epithelial ovarian tumors.

Authors:  Annika Idahl; Eva Lundin; Margaretha Jurstrand; Urban Kumlin; Fredrik Elgh; Nina Ohlson; Ulrika Ottander
Journal:  Infect Dis Obstet Gynecol       Date:  2011-07-28

3.  EphrinA2 receptor (EphA2) is an invasion and intracellular signaling receptor for Chlamydia trachomatis.

Authors:  Prema Subbarayal; Karthika Karunakaran; Ann-Cathrin Winkler; Marion Rother; Erik Gonzalez; Thomas F Meyer; Thomas Rudel
Journal:  PLoS Pathog       Date:  2015-04-23       Impact factor: 6.823

Review 4.  The potential role of infectious agents and pelvic inflammatory disease in ovarian carcinogenesis.

Authors:  Kasper Ingerslev; Estrid Hogdall; Tine Henrichsen Schnack; Wojciech Skovrider-Ruminski; Claus Hogdall; Jan Blaakaer
Journal:  Infect Agent Cancer       Date:  2017-05-18       Impact factor: 2.965

5.  Chlamydia trachomatis, Chlamydial Heat Shock Protein 60 and Anti-Chlamydial Antibodies in Women with Epithelial Ovarian Tumors.

Authors:  Sarah Jonsson; Husam Oda; Eva Lundin; Jan Olsson; Annika Idahl
Journal:  Transl Oncol       Date:  2018-03-07       Impact factor: 4.243

6.  Sexually transmitted infections and risk of epithelial ovarian cancer: results from the Nurses' Health Studies.

Authors:  Renée T Fortner; Kathryn L Terry; Noemi Bender; Nicole Brenner; Katrin Hufnagel; Julia Butt; Tim Waterboer; Shelley S Tworoger
Journal:  Br J Cancer       Date:  2019-03-21       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.